126458-16-0 Usage
Uses
Used in Pharmaceutical Industry:
(R)-2-Methyl piperazine (L)tartaric acid salt is used as an intermediate in drug synthesis for the development of antipsychotics and antidepressants, contributing to the creation of medications that address mental health conditions.
Used in Chemical Industry:
(R)-2-Methyl piperazine (L)tartaric acid salt is used as a compound in various chemical processes, potentially for the synthesis of other complex molecules or for research purposes, where its unique properties can be harnessed for specific applications.
Used in Culinary Applications:
(R)-2-Methyl piperazine (L)tartaric acid salt, due to the presence of L-tartaric acid, may be used as an acidulant in foods and beverages, providing a tart flavor and balancing the taste profile of certain products.
Check Digit Verification of cas no
The CAS Registry Mumber 126458-16-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,6,4,5 and 8 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 126458-16:
(8*1)+(7*2)+(6*6)+(5*4)+(4*5)+(3*8)+(2*1)+(1*6)=130
130 % 10 = 0
So 126458-16-0 is a valid CAS Registry Number.
InChI:InChI=1/C5H12N2.C4H6O6/c1-5-4-6-2-3-7-5;5-1(3(7)8)2(6)4(9)10/h5-7H,2-4H2,1H3;1-2,5-6H,(H,7,8)(H,9,10)/t5-;1-,2?/m11/s1
126458-16-0Relevant academic research and scientific papers
NOVEL PROCESS
-
Page 24-25, (2010/02/05)
The present invention relates to a process for the preparation of compounds which are therapeutically active in the central nervous system. In one aspect, the invention relates to a process for the preparation of compounds of the general formula (I). The invention also relates to (2R)-1-(3-chloro-2-pyrazinyl)-2-methylpiperazine, hydrochloride and a process for preparing the same. Another object of the present invention is a compound of the formula (I). Another object of the present invention is a method for the treatment or prophylaxis of a serotonin-related disorder, comprising administering to a subject in need thereof an effective amount of the compound above; as well as the use of said compound to manufacture a medicament for the treatment of a serotonin-related disorder.
